CORCEPT THERAPEUTICS INC — Director's Dealing 2021

Jan 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-01-22

Reporting Person: Robb Gary Charles (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-22	Common Stock	M	451852	$2.70	Acquired	459877	Direct
2021-01-22	Common Stock	F	258739	$28.06	Disposed	201138	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-22	Stock Option (Right to Buy)	$2.70	M	451852	Disposed	2021-09-01	Common Stock (451852)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4564	Indirect
Common Stock	4564	Indirect
Common Stock	4564	Indirect

Footnotes

F1: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2021. The options subject to the net exercise were to expire on September 1, 2021.

F2: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

F3: Fully exercisable.